| Indicators | Browse All

Drugs Made In America Acquisition Corp. (DMAA)

Financial Services | Shell Companies | New York, United States | NasdaqGM
10.85 USD

Short-term:★★⯪☆☆Long-term:★★⯪☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 10:33 a.m. EDT

The security is a shell company trading strictly at its redemption value, offering no intrinsic business value or growth potential. While the price has remained remarkably stable recently, hovering near the $10.85 mark, this stagnation reflects the reality of a vehicle awaiting a business combination rather than a viable investment thesis. The lack of any dividend history confirms there is no income component to consider. With a negative book value and significant debt relative to its tiny cash reserves, the balance sheet is fragile. The recent news of revised merger terms and shareholder class action investigations highlights the inherent risks and uncertainty surrounding such deals. Consequently, there is no clear directional edge for either short-term traders seeking momentum or long-term investors seeking fundamental appreciation.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.002468
AutoETS0.002469
MSTL0.002500
AutoTheta0.004132

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 82%
H-stat 17.78
Ljung-Box p 0.000
Jarque-Bera p 0.073
Excess Kurtosis -1.06
Attribute Value
Sector Financial Services
Market Cap 263,404,512
Trailing P/E 60.28

Info Dump

Attribute Value
52 Week Change 0.054368973
Address1 420 Lexington Avenue
Address2 Suite 1402
All Time High 10.89
All Time Low 9.95
Ask 10.54
Ask Size 5
Average Daily Volume10 Day 11,440
Average Daily Volume3 Month 21,367
Average Volume 21,367
Average Volume10Days 11,440
Bid 10.65
Bid Size 5
Book Value -0.305
City New York
Country United States
Crypto Tradeable 0
Currency USD
Current Price 10.85
Current Ratio 0.023
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 10.85
Day Low 10.85
Display Name Drugs Made In America
Dividend Yield 0.0
Earnings Growth -0.179
Earnings Quarterly Growth -0.245
Earnings Timestamp End 1,747,771,200
Earnings Timestamp Start 1,747,771,200
Ebitda Margins 0.0
Enterprise Value 263,976,992
Eps Trailing Twelve Months 0.18
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 10.7929
Fifty Day Average Change 0.057100296
Fifty Day Average Change Percent 0.0052905423
Fifty Two Week Change Percent 5.4368973
Fifty Two Week High 10.89
Fifty Two Week High Change -0.03999996
Fifty Two Week High Change Percent -0.003673091
Fifty Two Week Low 10.29
Fifty Two Week Low Change 0.5600004
Fifty Two Week Low Change Percent 0.05442181
Fifty Two Week Range 10.29 - 10.89
Financial Currency USD
First Trade Date Milliseconds 1,740,493,800,000
Float Shares 19,788,112
Full Exchange Name NasdaqGM
Fullday Change 0.0
Fullday Change Percent 0.0
Fullday Price 10.85
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Held Percent Insiders 0.23568001
Held Percent Institutions 0.53431
Implied Shares Outstanding 24,276,913
Industry Shell Companies
Industry Disp Shell Companies
Industry Key shell-companies
Ipo Expected Date 2,025-02-25
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Long Name Drugs Made In America Acquisition Corp.
Market us_market
Market Cap 263,404,512
Market State REGULAR
Max Age 86,400
Message Board Id finmb_1889535116
Most Recent Quarter 1,782,777,600
Net Income To Common 6,094,877
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 263,404,506
Open 10.85
Operating Cashflow -517,145
Operating Margins 0.0
Payout Ratio 0.0
Phone 646 726 7074
Previous Close 10.85
Price Hint 2
Price To Book -35.573772
Profit Margins 0.0
Quick Ratio 0.007
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0
Regular Market Change Percent 0.0
Regular Market Day High 10.85
Regular Market Day Low 10.85
Regular Market Day Range 10.85 - 10.85
Regular Market Open 10.85
Regular Market Previous Close 10.85
Regular Market Price 10.85
Regular Market Time 1,791,835,200
Regular Market Volume 9
Sand P52 Week Change 0.17004645
Sector Financial Services
Sector Disp Financial Services
Sector Key financial-services
Shares Outstanding 24,276,913
Shares Percent Shares Out 0.0037
Shares Short 89,787
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 79,392
Short Name Drugs Made In America Acquisiti
Short Percent Of Float 0.0045
Short Ratio 2.43
Source Interval 15
State NY
Symbol DMAA
Total Cash 20,280
Total Cash Per Share 0.001
Total Debt 350,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps 0.18
Trailing P E 60.27778
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 10.59994
Two Hundred Day Average Change 0.25006008
Two Hundred Day Average Change Percent 0.023590706
Type Disp Equity
Volume 9
Zip 10,170